Nexgel, Inc. (NASDAQ: NXGL) provides ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Nexgel, Inc. (NASDAQ: NXGL) Market Cap: $19.56; Current Share Price: 3.14 USD Data by YCharts The Company and its Products Nexgel manufactures high-water-content, electron beam cross-linked, aqueous polymer hydrogels or gels for wound care, medical diagnostics,...
Zynex, Inc. (Nasdaq: ZYXI) is an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company and its Products As of December 31, 2022, the Company’s active subsidiaries are Zynex Medical, Inc. (ZMI) and Zynex Monitoring...
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) recently announced that the U.S. Food and Drug Administration has granted approval of its New Drug Application (NDA) for naloxone hydrochloride nasal spray 4mg, which is delivered utilizing the Company's proprietary nasal delivery device. Naloxone hydrochloride nasal spray 4mg is...
Pandion Therapeutics, Inc. (NASDAQ: PAND), a clinical-stage biotechnology company developing modular biologics for autoimmune regulation, has entered into a definitive agreement with Merck (NYSE: MRK) to be acquired for $60 per share in cash, for an approximate total equity value of $1.85 billion. The acquisition...
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is in the spotlight after receiving a “Buy” rating along with a $30 price target from Ram Selvaraju an analyst at H.C Wainwright, implying a nearly 275% upside from its current levels. We take a look at reasons for the...
